Table 3 Reconstruction for chronic arterial occlusive diseases*10): Table 3-1 Arterial reconstruction for aortic arches.
| Aortic branches | Cases | Gender | Mortality | Background | Etiology | Revascularization procedures | Graft materials*14) | Previous reconstruction | Revision site | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | 30-day mortality | Dialysis | ASO | TAO | Vasculitis*11) | Takayasu arteritis | Debranch for EVAR/ TEVAR | Others | CAS | CEA | PTA/stent*13) | Replacement | Visceral artery bypass | Internal iliac artery bypass | Anatomical bypass | Carotid-subclavian bypass | Axillo-axillar bypass | Others | Polyester | ePTFE | Autogenous veins | Others | None | Once | Twice | Three times and more | Unclear | Host artery stenosis/occlusion | Graft/EVT stenosis | Graft/EVT occlusion | Other | Unclear | ||||
| Cases | Brain complication*12) | Cases | Brain complication*12) | Cases | |||||||||||||||||||||||||||||||||
| Carotid artery | 84 | 69 | 15 | 1 | 3 | 61 | 0 | 2 | 1 | 15 | 5 | 7 | 0 | 50 | 2 | 5 | 2 | 0 | 1 | 3 | 14 | 10 | 4 | 7 | 14 | 1 | 1 | 78 | 4 | 0 | 1 | 1 | 3 | 0 | 0 | 2 | 0 |
| Vertebral artery | 2 | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Subclavian artery | 116 | 86 | 30 | 1 | 5 | 78 | 2 | 0 | 2 | 26 | 8 | 1 | 0 | 0 | 0 | 50 | 1 | 0 | 0 | 5 | 21 | 43 | 8 | 19 | 44 | 1 | 0 | 106 | 5 | 1 | 2 | 2 | 5 | 1 | 1 | 1 | 0 |
| Multiple lesions of arch branches | 7 | 4 | 3 | 1 | 0 | 4 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 4 | 1 | 2 | 3 | 0 | 0 | 6 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Upper limb including axillar artery | 93 | 68 | 25 | 3 | 43 | 67 | 1 | 0 | 0 | 6 | 19 | 0 | 0 | 1 | 0 | 41 | 2 | 0 | 0 | 10 | 2 | 9 | 33 | 10 | 8 | 7 | 0 | 69 | 15 | 5 | 4 | 0 | 11 | 2 | 5 | 6 | 0 |
| Celiac/Superior mesenteric artery | 73 | 49 | 24 | 2 | 11 | 54 | 0 | 0 | 2 | 5 | 12 | 0 | 0 | 0 | 0 | 30 | 4 | 19 | 4 | 3 | 0 | 0 | 15 | 7 | 1 | 0 | 0 | 64 | 8 | 1 | 0 | 0 | 7 | 0 | 1 | 1 | 0 |
| Renal artery | 88 | 65 | 23 | 1 | 1 | 73 | 0 | 0 | 0 | 4 | 11 | 0 | 0 | 0 | 0 | 76 | 2 | 5 | 0 | 2 | 0 | 0 | 3 | 3 | 3 | 1 | 0 | 80 | 6 | 2 | 0 | 0 | 5 | 2 | 1 | 0 | 0 |
| Others | 321 | 254 | 67 | 7 | 12 | 26 | 0 | 0 | 0 | 281 | 14 | 0 | 0 | 0 | 0 | 25 | 0 | 24 | 9 | 32 | 118 | 155 | 46 | 124 | 123 | 2 | 8 | 306 | 10 | 3 | 0 | 2 | 10 | 1 | 0 | 2 | 0 |
| Total | 754 | 576 | 178 | 16 | 73 | 357 | 3 | 2 | 4 | 320 | 68 | 8 | 0 | 51 | 2 | 224 | 11 | 46 | 13 | 51 | 141 | 210 | 106 | 164 | 183 | 12 | 8 | 683 | 47 | 11 | 7 | 6 | 39 | 6 | 8 | 12 | 0 |
＊10) Bypass surgery combined with endovascular treatment is counted in both bypass category (Table 3-2) and endovascular category (Table 3-5). ＊11) Including TAO, Takayasu arteritis, coarctation of aorta, collagen disease related vasculitis, Behcet disease, fibromuscular dysplasia. ＊12) Postoperative irreversible brain complication. ＊13) Including percutaneous transluminal angioplasty (PTA), stent, and other endovascular means such as catheter atherectomy. ＊14) Only for open surgery.